Latest issueTuesday, September 29, 2026
5 deals · Updated Tue, Sep 29, 2026 at 10:01 AM PDT·Full deal sheet
Add-on·Healthcare/Life Sciences Tools / Services·September 28, 2026

Renovus-backed TJP acquires Evolution Consulting & Research

Creates a unified life sciences offering that connects market research, strategy, creative, and field execution for pharmaceutical and biotech clients.

More healthcare deals →

BuyerTJP
TargetEvolution Consulting & Research
SponsorRenovus Capital Partners
TypeAdd-on
IndustryHealthcare
Sub-sectorLife Sciences Tools / Services

Evolution Consulting & Research, a specialized market research consultancy serving global life sciences organizations, has joined TJP, a Renovus Capital Partners portfolio company. The firm provides qualitative and quantitative research to pharmaceutical and biotechnology manufacturers, informing commercial decisions, brand positioning, and market access strategies.

The deal adds market research expertise to TJP's integrated life sciences offering spanning research, strategy, creative, pull-through, and analytics, following the earlier addition of FX2 Virtual's commercial deployment infrastructure. "Joining forces with TJP and Renovus Capital Partners represents an exciting new chapter for Evolution and our clients," said Mike Heasley, Partner of Evolution Consulting & Research.

TJP, founded in 1972 and recognized as an MM+M Top 100 Agency, specializes in value and patient access for life sciences and strategy-led creative for consumer brands.